Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT02052024 : Myobloc Atrophy Study
PhasePhase 4
AgesMin: 18 Years Max: N/A
Eligibility
Inclusion Criteria:

- Men and women aged 18 or older with spasticity secondary to either a disorder or
trauma, such as a spinal cord injury (SCI), a brain injury, a tumor, a stroke,
multiple sclerosis (MS), or a peripheral nerve injury.

- Participants must have the ability to provide written consent to participate in the
study.

Exclusion Criteria:

- Patients who have received BTX-A or BTX-B in the past in the skeletal muscle group
under investigation or patients who have had an allergic response to BTX-A or BTX-B
in the past.

- Diagnosis of Myasthenia gravis, Eaton-Lambert Syndrome, or Amyotrophic Lateral
Sclerosis. Females who are pregnant or breastfeeding. Subjects taking Aminoglycosides
or other agents interfering with neuromuscular function.
LinksPermanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT02052024      |      Link to official Clinicaltrials.gov listing
Locations



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740